Showing results (41-50 of 94) with videos related to

Sort By:
Pageof 10
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 5, 2016
Genomic profiling of malignant peritoneal mesothelioma reveals recurrent alterations in epigenetic regulatory genes BAP1, SETD2, and DDX3XNancy M Joseph, Yunn-Yi Chen, Anthony Nasr, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 4, 2020
Primary mammary angiosarcomas harbor frequent mutations in KDR and PIK3CA and show evidence of distinct pathogenesisFrancisco Beca, Gregor Krings, Yunn-Yi Chen, et al.
The American Journal of Surgical Pathology|March 20, 2023
HER2 IHC Expression and Gene Amplification in p53-aberrant High-grade Endometrial Endometrioid Carcinoma Suggests That This Population May Benefit From HER2 Testing and Targeted TherapyAmy S Joehlin-Price, Miglena K Komforti, Nicholas R Ladwig, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 4, 2023
Triple-Negative Apocrine Carcinomas: Toward a Unified Group With Shared Molecular Features and Clinical BehaviorChristopher J Schwartz, Jeanette Ruiz, Gregory R Bean, et al.
Biorxiv : the Preprint Server for Biology|March 31, 2025
NCOR2 represses MHC class I molecule expression to drive metastatic progression of breast cancerPavla Ticha, Jason J Northey, Kelly Kersten, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 10, 2023
Loss of PPARγ activity characterizes early protumorigenic stromal reprogramming and dictates the therapeutic window of opportunityJoseph A Caruso, Xianhong Wang, Lyndsay M Murrow, et al.
Cancer Research|November 13, 2003
Differentiation of lobular versus ductal breast carcinomas by expression microarray analysisJames E Korkola, Sandy DeVries, Jane Fridlyand, et al.
BMC Cancer|April 13, 2007
Identification of a robust gene signature that predicts breast cancer outcome in independent data setsJames E Korkola, Ekaterina Blaveri, Sandy DeVries, et al.
Annals of Surgical Oncology|August 8, 2024
Change in Biomarker Profile After Neoadjuvant Chemotherapy is Prognostic and Common Among Patients with HER2+ Breast CancerJulia Tchou, Soumy Gottipati, Macy Goldbach, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 18, 2024
Targeted DNA Sequencing in Diagnosis of Malignant Phyllodes Tumors With Emphasis on Tumors With Keratin and p63 ExpressionJulia Ye, Talent Theparee, Gregory R Bean, et al.
Pageof 10